BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28099084)

  • 1. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
    Mavragani CP
    Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
    Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
    Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome.
    Thompson N; Isenberg DA; Jury EC; Ciurtin C
    Rheumatology (Oxford); 2016 Sep; 55(9):1548-55. PubMed ID: 26790457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome.
    Mavragani CP; Moutsopoulos HM
    Annu Rev Pathol; 2014; 9():273-85. PubMed ID: 24050623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome: Old and new therapeutic targets.
    Mavragani CP; Moutsopoulos HM
    J Autoimmun; 2020 Jun; 110():102364. PubMed ID: 31831255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell hyperactivity in primary Sjögren's syndrome.
    Kroese FG; Abdulahad WH; Haacke E; Bos NA; Vissink A; Bootsma H
    Expert Rev Clin Immunol; 2014 Apr; 10(4):483-99. PubMed ID: 24564507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell populations and sub-populations in Sjögren's syndrome.
    Hamza N; Bos NA; Kallenberg CG
    Presse Med; 2012 Sep; 41(9 Pt 2):e475-83. PubMed ID: 22841377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.
    Carrillo-Ballesteros FJ; Palafox-Sánchez CA; Franco-Topete RA; Muñoz-Valle JF; Orozco-Barocio G; Martínez-Bonilla GE; Gómez-López CE; Marín-Rosales M; López-Villalobos EF; Luquin S; Castañeda-Chávez A; Oregon-Romero E
    Clin Exp Med; 2020 Nov; 20(4):615-626. PubMed ID: 32506205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome.
    Shimizu T; Nakamura H; Kawakami A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood gene expression profiling in Sjögren's syndrome.
    Emamian ES; Leon JM; Lessard CJ; Grandits M; Baechler EC; Gaffney PM; Segal B; Rhodus NL; Moser KL
    Genes Immun; 2009 Jun; 10(4):285-96. PubMed ID: 19404300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of B cells in Sjögren's syndrome--from benign lymphoproliferation to overt malignancy.
    Jonsson R; Nginamau E; Szyszko E; Brokstad KA
    Front Biosci; 2007 Jan; 12():2159-70. PubMed ID: 17127453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary Gland Pathology in Sjögren's Syndrome.
    Campos J; Hillen MR; Barone F
    Rheum Dis Clin North Am; 2016 Aug; 42(3):473-83. PubMed ID: 27431349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.
    Szodoray P; Alex P; Jonsson MV; Knowlton N; Dozmorov I; Nakken B; Delaleu N; Jonsson R; Centola M
    Clin Immunol; 2005 Nov; 117(2):168-76. PubMed ID: 16126006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the type I interferon pathway in primary Sjogren's syndrome.
    Mavragani CP; Crow MK
    J Autoimmun; 2010 Nov; 35(3):225-31. PubMed ID: 20674271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-lymphocytes govern the pathogenesis of Sjögren's syndrome.
    Youinou P; Saraux A; Pers JO
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2071-7. PubMed ID: 22208653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome.
    Abdulahad WH; Kroese FG; Vissink A; Bootsma H
    J Autoimmun; 2012 Aug; 39(1-2):103-11. PubMed ID: 22341852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies.
    Nguyen CQ; Cha SR; Peck AB
    Front Biosci; 2007 Jan; 12():1767-89. PubMed ID: 17127420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [B lymphocytes in Sjögren's syndrome].
    Pers JO; Le Pottier L; Devauchelle V; Saraux A; Youinou P
    Rev Med Interne; 2008 Dec; 29(12):1000-6. PubMed ID: 18403061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
    Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.